Oric Pharmaceuticals shares are trading higher after Jones Trading initiated coverage on the stock with a Buy rating and announced a price target of $17.
Portfolio Pulse from Benzinga Newsdesk
Oric Pharmaceuticals shares rose after Jones Trading initiated coverage with a Buy rating and set a price target of $17.
October 31, 2024 | 1:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oric Pharmaceuticals shares increased following a Buy rating and a $17 price target from Jones Trading.
The initiation of coverage with a Buy rating and a specific price target by a reputable firm like Jones Trading is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100